Jaguar Health, Inc. (JAGX)
0.855
-0.58
(-40.21%)
USD |
NASDAQ |
Jan 20, 16:00
0.807
-0.05
(-5.61%)
After-Hours: 07:27
Jaguar Health EPS Diluted (Quarterly): -6.280 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Abbott Laboratories | 0.9146 |
| Merck & Co., Inc. | 2.316 |
| Outset Medical, Inc. | -1.003 |
| Moderna, Inc. | -0.5128 |
| NovaBay Pharmaceuticals, Inc. | -0.22 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -9.648M |
| Revenue (Quarterly) | 3.083M |
| Total Expenses (Quarterly) | 12.58M |
| Enterprise Value | 30.67M |
| Gross Profit Margin (Quarterly) | 64.58% |
| Profit Margin (Quarterly) | -312.9% |
| Earnings Yield | -3.97K% |
| Normalized Earnings Yield | -3425.27 |